Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which airway method is safer for Single-Lung ventilation during heart surgery?

NCT ID NCT06299735

Knowledge-focused Sponsor: Ankara City Hospital Bilkent Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at two ways to manage breathing during heart surgery that requires one lung to be deflated. Researchers compared using a double-lumen tube versus a bronchial blocker in 66 patients. They checked for lung problems after surgery, how long it took to place the device, and how well the lung collapsed. The goal is to find which method leads to better recovery and fewer complications.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If one method proves better, it could guide anesthesiologists in choosing the safest airway technique for patients needing single-lung ventilation during heart surgery.
What could go wrong
This is a small, completed study with only 66 participants, so results may not apply to all patients. It compares techniques, not a new treatment, so no major breakthrough is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

66 people

The number who actually took part.

Started

Apr 2024

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients planned for on-pump minimal invasive cardiac surgical procedures requiring single-lung ventilation * Female and male patients aged 18 and above * Patients with ASA scores of 1-2-3 * Patients with signed informed consent to participate in the study * Patients with a Body Mass Index (BMI) less than 40 Exclusion Criteria: * Emergency surgeries * Patients with ASA scores greater than 3 * Advanced-stage organ (heart, kidney, liver, lung) failure * Advanced lung diseases (COPD, FEV1\<50%, restrictive lung diseases, history of chest surgery, Pulmonary Hypertension, PAB\>30mmHg) * Patients with anticipated difficult intubation * Pregnant individuals * Patients with a BMI greater than 40 * Patients lacking the ability to read, understand, sign the informed consent form, and those who do not wish to participate in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary arteriosclerosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cardiac valvular defect coronary artery disorder heart valve disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary arteriosclerosis Heart valvular disease One-lung ventilation

Contacts and locations

Locations

  • Ankara bilkent city hospital

    Ankara, Çankaya, 06530, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.